Environmental exposure to xenoestrogens and oestrogen related cancers: Reproductive system, breast, lung, kidney, pancreas, and brain

Environmental Health: A Global Access Science Source

Volumn 11, Issue SUPPL.1, 2012, Pages

  Fucic, Aleksandra ^a   Gamulin, Marija ^b   Ferencic, Zeljko ^c   Katic, Jelena ^a   Krayer Von Krauss, Martin ^d   Bartonova, Alena ^e   Merlo, Domenico F ^f  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b KBC Zagreb   (Croatia)

^c Children Hospital Srebrnjak   (Croatia)

^d WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^e NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; ESTROGEN; UNCLASSIFIED DRUG; XENOESTROGEN; ESTROGEN RECEPTOR;

ANTHROPOGENIC EFFECT; BIOMONITORING; BRAIN; CANCER; DECADAL VARIATION; ENDOCRINE DISRUPTOR; ENVIRONMENTAL PROTECTION; ENZYME ACTIVITY; ESTROGENIC COMPOUND; HOMEOSTASIS; POLLUTION EXPOSURE; REPRODUCTIVE HEALTH; STEROID;

BRAIN CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; DATA MINING; ENVIRONMENTAL EXPOSURE; GYNECOLOGIC CANCER; HUMAN; KIDNEY CANCER; LUNG CANCER; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TESTIS CANCER; DRUG EFFECT; FEMALE; MALE;

ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ESTROGENS; FEMALE; HUMANS; MALE; NEOPLASMS; RECEPTORS, ESTROGEN; SEX FACTORS;

EID: 84863299898     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-11-S1-S8     Document Type: Review

References (128)

1. Cancer in children and adolescence in Europe: developments over 20 years and future challenges. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JWW, European J Cancer 2006 42 2183 2190 (Pubitemid 44224065)
2. Estimates of the incidence and mortality in Europe in 2. Ferlay J, Autier P, Boniol M, Heaune M, Colombet M, Boyle P, Annals of Oncology 2007 18 581 592
3. Estrogen: nontranscriptional signaling pathway. Moss RL, Gu O, Wong M, Recent Prog Horm Res 1997 52 33 68 (Pubitemid 127470205)
4. Acute effects of estrogen on neuronal physiology. Wooley CS, Ann RevPharmacol Toxicol 2007 47 657 80
5. Is the role of estrogens and estrogen receptors in epilepsy still underestimated? Fucic A, Mikov S, Zeljezic D, Bogdanovic N, Katic J, Gjergja R, Karelson E, Gamulin M, Medical Hypotheses 2009 73 703 705
6. Estrogen and its receptors in cancer. Chen GC, Zeng Q, Tse GMK, Med Res Review 2008 28 6 954 974
7. Androgenic/estrogenic balance in the male rat cerebral circulation: metabolic enzymes and sex steroid receptors. Gonzales RJ, Ansar S, Duckles SP, Krause DN, J Cereb Blood Flow Metab 2007 27 11 1841 1852 (Pubitemid 47624548)
8. Tissue and time dependent estrogen receptor activation in estrogen reporter mice. Lemmen JG, Arends RJ, van Boxtel AL, van der Saag PT, van der Burg B, J Mol Endocrinol 2004 32 689 701 (Pubitemid 38877682)
9. Estrogen DNA damage and mutations. Roy D, Liehr JG, Mutat Res 1999 424 107 115
10. Immunolocaliosation of oestrogen receptors alpha (Eralpha) and beta (Erbeta) in porcine embryos and fetuses at different stages of gestation. Knapczyk K, Duda M, Szafranska B, Wolsza K, Panasiewicz G, Koziorowski M, Slomczynska M, Acta Vet Hung 2008 56 2 221 233
11. Tissue distribution of estrogen receptors alpha (Er) and beta (Er) mRNA in the midgestational human fetus. Branderberger AW, Tee MK, Lee JY, Chao V, Jaffe RB, J Clin Endocrinol & Metabolism 1997 82 10 3509 3512 (Pubitemid 27419113)
12. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC, Cancer Res 2004 64 1 423 428 (Pubitemid 38114127)
13. ER alpha genotypes and breast cancer. Grabinski JL, Chisholm G, Smith LS, Drengler RL, Kalter S, Rodriguez G, Garner A, Cooper J, Pollock B, Kuhn J, J Clin Oncol 2008 26 15S 501
14. Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in taret promotor regulation by xenoestrogens. Hall JM, Korach KS, J Biol Chem 2002 277 46 44455 44461 (Pubitemid 36157880)
15. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Cavalieri EL, Stack DE, Devanesan PD, Proc Nat Acad Sci USA 1997 94 10937 10942 (Pubitemid 27430839)
16. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage and estrogen dependent cancers. Roy D, Cai Q, Felty Q, Narayan S, J Toxicol Environ Health, Part B 2007 10 4 235 257 (Pubitemid 47057178)
17. Minisatellite germline mutation rate in the Techa River population. Dubrova YE, Ploshchanskaya OG, Kozionova OS, Akleyev AV, Mutat Res 2006 602 1-2 74 82 (Pubitemid 44767849)
18. Radiation-induced genomic instability is associated with DNA methylation changes in cultured human keratinocytes. Kaup S, Grandjean V, Mukherjee R, Kapoor A, Keyes E, Seymour CB, Mothersill CE, Schofield PN, Mutat Res 2006 597 1-2 87 97 (Pubitemid 44316632)
19. Genotoxicity of the steroidal oestrogens oestrone and oestradiol:possible mechanism of uterine and mammary cancer development. Liehr JG, Hum Reprod Update 2001 7 3 273 281 (Pubitemid 32440289)
20. In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Ansell PJ, Espinosa-Nicholas C, Curran EM, Judy BM, Philips BJ, Hannink M, Lubahn DB, Endocrinology 2004 145 1 311 7 (Pubitemid 38094525)
21. Are there sex and gender differences in acute exposure to cheicals n the same setting? Arbuckle TE, Environ Res 2006 101 195 204 (Pubitemid 44262211)
22. Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methychlor in CD-1 M, Effects of low versus high doses. Alworth LC, Howdesshell KL, Ruhlen RL, Day JK, Lubahn DB, Huang HM, Besch-Williford CL, Saal FS, Toxicol Appl Pharmacol 2002 183 10 22
23. Estrogen modulates developmentaly regulated gene expression in the fetal baboon liver. Rosenthal MD, Albrecht ED, Pepe GJ, Endocrine 2004 23 2-3 219 228 (Pubitemid 39140236)
24. Environmental oestrogens, cosmetics and breast cancer. Best Practice & Research. Darbre PD, Clin Endocrinol & Metabolism 2006 20 1 121 143 (Pubitemid 43328572)
25. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. Barbieri RL, Gochberg J, Ryan KJ, J Clin Invest 1986 77 6 1727 1733 (Pubitemid 16062622)
26. Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant women. Wang SL, Chang YC, Chao HR, Li CM, Li LA, Lin LY, Papke O, EHP 2006 114 5 740 745
27. In utero exposure to benzophenone-2 causes hypospadias through an estrogen receptor dependent mechanisms. Hsieh M, Grantha E, Liu B, Macapagai R, Willingham E, Baskin LS, J Urol 2007 178 1637 1642 (Pubitemid 47376726)
28. Cancer and developmental exposure to endocrine disruptors. Birnbaum LS, Fenton S, EHP 2003 111 4 389 394 (Pubitemid 36546511)
29. Estrogen effects in vitro and in vivo of the fungicide fenarimol. Andersen HR, Bonefeld-Jorgensen EC, Nielsen F, Jarfeldt K, Jayatissa MN, Vinggaard AM, Toxicol Lett 2006 163 2 142 152
30. Changes in breast cancer incidence and mortlaity in middle-aged and elderly women in 28 countries with Causcasian mjaroty populations. Hery C, Ferlay J, Boniol M, Autier P, Annals of Oncology 2008 19 1009 1018 (Pubitemid 351627322)
31. Estrogen-induced at breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression. Kovalchuk O, Tryndiyak P, Montgomery B, Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR, Kovalchuk I, Beland FA, Pogrybny IP, Cell Cycle 2007 6 16 2010 8 (Pubitemid 47327889)
32. Estrogens and breast cancer. Feigelson HS, Henderson BE, Carcinogenesis 1996 17 11 2279 84 (Pubitemid 26402222)
33. Study design:evaluating gene-environment interactions in the etiology of breast cancer- the WECARE study. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstien BS, Borresen-Dale AL, Concannon P, Thompson WD, Breast Cancer Res 2004 6 199 214
34. Breast cancer and environmental risks: where is the link? Mitra AK, Faruque FS, Avis AL, J Environ Health 2004 66 7 24 32 (Pubitemid 38327280)
35. Serum polychlorinated biphenyls P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Zhang Y, Wise JP, Holford TR, Xie H, Boyle P, Hoar Zahm SH, Rusiecki J, Zou K, Zhang B, Zhu Y, Owens PH, Zheng T, Am J Epidemiol 2004 160 1177 1183 (Pubitemid 39628058)
36. Exposure to traffic emissions through life and risk of breast cancer: the western New Your exposure and breast cancer (WEB) study. Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL, Cancer Causes & Control 2007 18 9 947 955 (Pubitemid 47237958)
37. In utero alcohol exposure increases mammary tumorigenesis in rats. Hilakivi-Clarke L, Cabanes A, de Assis S, Wang M, Khan G, Shoemaker WJ, Stevens RG, Brit J Cancer 2004 90 2225 2231 (Pubitemid 38869734)
38. The role of early life genistein exposures in modifying breast cancer risk. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L, BJC 2008 98 1485 1493 (Pubitemid 351652325)
39. Stem cells and prenatal origin of breast cancer. Baik I, Becker PS, DeVito WJ, Lagiou P, Ballen K, Quesenberry PJ, Hsieh P, Cancer Causes and Control 2004 15 517 530 (Pubitemid 39060944)
40. Environmental pollutants and breast cancer. Brody JG, Rudel RA, EHP 2003 111 8 1007 19 (Pubitemid 36826882)
41. Breast cancer risk and drinking water contaminated by wastewater: a case control study. Brody JG, Aschengrau A, McKelvey W, Swartz CH, Kennedy T, Rudel RA, Environ Health 2006 6 5 28
42. Environmental pollutants, diet, physical activity, body size and breast cancer. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfiled KR, Gray S, Cancer (Suppl) 2007 109 12 2627 2634
43. Risk factor in alcohol associated breast cancer: Alcohol dehydrogenase polymorphism and estrogens. Coutelle C, Hohn B, Benesova M, Oneta CM, Quattrochi P, Roth HJ, Schmidt-Gayk H, Schneeweiss A, Bastert G, Seitz HK, Int J Oncology 2004 25 4 1127 1132
44. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, Rosen EM, Cancer Res 2000 60 5635 5639
45. The experience of Japan as a clue to the etiology of breast and ovarian cancers: relatioship between death from both malignancies and dietary practices. Li XM, Ganmma D, Sato A, Med Hypothesis 2003 60 2 268 275 (Pubitemid 36194301)
46. The possible role of female sex hormones in milk from cows in the development of breast, ovarian and corpus uteri cancers. Ganmaa D, Sato A, Medical Hypothesis 2005 65 1028 1037 (Pubitemid 41430335)
47. Is milk repossible for male reproductive disorders. Ganmaa D, Wang PY, Qin LQ, Hoshi K, Sato A, Med Hypothesis 2001 57 510 514 (Pubitemid 33052047)
48. PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor. Bennion BJ, Cosman M, Lightstone FC, Knize MG, Montgomery JL, Bennett LM, Felton JS, Kulp KS, Chem Res Toxicol 2005 18 1528 1536 (Pubitemid 41504472)
49. The cooked meat-derived genotoxic carcinogen 2-amino-3-methylimidazol (4,5-b) pyridine has potent hormone-like activity: mechanistic support for a role in breast cancer. Lauber SN, Gooderham NJ, Cancer Res 2007 67 9597 9602 (Pubitemid 47535952)
50. A new colon and mammary carcinogen in cooked food 2-amino-1-methyl-6- phenylimidazo (4,5b)pyridine (PhIP). Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T, Carcinogenesis 1991 12 1503 1506
51. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine in rats: possible mechanisms. Snyderwine EG, Cancer Lett 1999 143 2 211 5 (Pubitemid 29392959)
52. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Bonner MR, Han D, Nie J, Rogerson P, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL, Cancer Epidemiol Biomarkers Prev 2005 14 1 53 60 (Pubitemid 40165283)
53. An ecological study of the association of environmental chemicals on breast cancer incidence in Texas. Coyle YM, Hynan LS, Euhus DM, Minhajuddin ATM, Breast Cancer Res Treatment 2005 92 107 114 (Pubitemid 40933574)
54. Certain styrene oligomers have proliferative activity on MCF-7 cells and binding affinity for human estrogen receptor alpha. Ohayama K, Magai F, Tsuchiya Y, EHP 2001 109 699 703 (Pubitemid 32785426)
55. Effects of prenatal exposure to styrene trimers on genital organs and hormones in male rats. Ohyama KI, Satoh K, Sakamoto Y, Ogata A, Nagai F, Exp Biol Med 2007 232 2 301 308 (Pubitemid 46203299)
56. Estrogenic activity of styrene oligomers after metabolic activation by rat liver microsomes. Kitamura S, Ohmegi M, Sanoh S, Sugihara K, Yoshihara S, Fujimoto N, Ohta S, EHP 111 3 329 334
57. Polychlorinated byphenyls contamination in women with breast cancer. Charlier CJ, Albert AI, Zhang L, Dubois NG, Plomteux GJ, Clin Chimaca Acta 2004 347 177 181 (Pubitemid 39099620)
58. Environmental exposure to plychlorinated biphenyls and breast cancer risk. Moysich KB, Menezes RJ, Baker JA, Falkner KL, Rev Environ Health 2002 17 4 263 277 (Pubitemid 36222133)
59. Human cancer from environmental pollutants: the epidemiological evidence. Boffetta P, Mutat Res 2006 608 157 162 (Pubitemid 44311607)
60. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological response to estrogen. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Cancer Res 2002 62 2141 2150 (Pubitemid 34408463)
61. Gender dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Fasco MJ, Hurteau GJ, Spivack SD, Mol Cell Endocrinol 2002 188 1-2 125 140 (Pubitemid 34242672)
62. Sex and gender differences in lung cancer. Stabile LP, Siefried JM, J Gend Specif Med 2003 6 1 37 48 (Pubitemid 36410481)
63. Lung cancer in women: the difference in epidemiology, biology and treatment outcomes. Rivera MP, Expert Rev Resp Med 2009 3 6 627 634
64. Gender differences in lung cancer: have we really come a long way, baby? Olak J, Colson Y, J Thorac Cardiovasc Surg 2004 128 346 351 (Pubitemid 39194686)
65. Cancer Statistics. Jemal A, Siegel R, Ward E, Cancer J Clin 2006 56 106
66. Outdoor air pollution and cancer: recent epidemiologic evidence. Vineis P, Forastiere F, Hoek G, Lipsett M, Int J Cancer 2004 111 647 652 (Pubitemid 39062885)
67. Environmental exposure to carcinogens causinglung cancer: epidemiological evidence from the medical literature. Whitrow MJ, Smith BJ, Pilotto LS, Pisaniello D, Nitschke M, Respirology 2003 8 513 521 (Pubitemid 38009649)
68. Cancer mortality and residence near petrochemical industries in Taiwan. Yang CY, Chiu HF, Chiu JF, Kao WY, Tsai SS, Lan SJ, J Toxicol Environ Health 1997 50 265 273
69. Nongenomic beta estrogen receptor enchance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone in human small airway epithelial cells. Majidi M, Al-Wadel HA, Takahashi T, Schuller HM, Cancer Res 2007 67 6863 6874
70. Air pollution and lung cancer risks in China- a meta-analysis. Zhao Y, Wang S, Aunan K, Seip HM, Hao J, Sci Total Environ 2006 366 500 513 (Pubitemid 44037686)
71. Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada. Ramanakumar AV, Parent ME, Siemiatycki J, Am J Epidemiol 2007 165 634 642 (Pubitemid 46348381)
72. Nuclear estrogen receptorbeta in lung cancer: expression and survival differences by sex. Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J, Brooks S, Imaging, Diagnosis, Prognosis 2005 11 20 7280 7287 (Pubitemid 41507685)
73. Oestrogen receptor beta over expression in males with non-small cell cancer is associated with beter survival. Skov BG, Fischer BM, Pappot H, Lung Cancer 2008 59 1 88 94
74. Estrogen and its signaling pathway in non-small cell lung cancer (NSCLC). Xu R, Shu Y, J Najing Med Univ 2009 23 4 217 223
75. Ontogenetic expression of estrogen and progesterone receptors in the mouse lung. Beyer C, Küppers E, Karolczak M, Trotter A, Biol Neonate 2003 84 1 59 63 (Pubitemid 36928732)
76. Expression of cytochrome P450 in non-small lung cancer. Oyama T, Sugio K, Isse T, Matsumoto A, Uramoto NH, Nozoe T, Morita M, Kagawa N, Muto TM, Yasumoto K, Kawamoto T, Frontiers Biosci 2008 13 5787 5793
77. Lung cancer and hormone replacement therapy:association in the vitamins and lifestyle study. Slatore CG, Chien JW, Au DH, Satia JA, White E, J Clin Oncol 2010 28 9 1540 1546
78. Risk factors differ for non-small-cell lung cancer with and without EFGR mutation:assessment of smoking and sex by a case-control study in Japanese. Matsuo K, Ito H, Yatabe Y, Hiraki A, Hirose K, Wakai K, Cancer Sci 2007 98 1 96 101 (Pubitemid 44803926)
79. Environmental causes of lung cancer: what do we know in 2003? Samet JM, Chest 2004 125 80 83
80. Maternal tobacco smoking, nicotine replacement and neurobeahavioural development. Pauly JR, Slotkin TA, Acta Paediatrica 2008 97 10 1331 1337
81. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat. Sarasin A, Schlumpf M, Muller M, Fleishmann I, Lauber ME, Lichtenstein, Reprod Toxicol 2003 17 2 153 162 (Pubitemid 36428309)
82. Waking a sleeping ginat: the tobacco industry's response to the Polonium-210 issue. Muggi ME, Elbert JO, Robertson C, Hurt RD, Am J Pub Health 2008 98 9 1643 1650
83. Drinking water with Uranium below the US EPA water standard causes estrogen receptor-dependent responses in female mice. Raymond-Whish S, Mayer LP, O'Neal T, Martinez A, Sellers MA, Christian PJ, Marion SL, Begay C, Propper CR, Hoyer PB, Dyer CA, EHP 2007 115 12 1711 1716
84. Long-term effects of traffic-related air pollution on mortality in a Ducth cohort (NLCS-AIR Study). Beelen R, Hoek G, van den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, Jerrett M, Hughes E, Armstrong B, Brunekreef B, EHP 2008 116 2 196 202 (Pubitemid 351356726)
85. Reduction in fine particulate air pollution and mortality. Laden F, Schwartz J, Speizer FE, Dockery DW, Am J Respir Crit Care Med 2006 173 667 672
86. Aryl hydrocarbon receptor and estrogen receptor ligand activity of organic exctracts from road dust and diesel exhaust particulates. Misaki K, Suzuki M, Nakamura M, Handa H, Iida M, Kato T, Matsui S, Matsuda T, Arch Environ Contam Toxicol 2008 55 199 209
87. Waste crankcase oil: an environmental contaminant with potential to modulate estrogenic responses. Ssempebwa JC, Carpenter DO, Yilmaz B, DeCaprio AP, O'Hehir DJ, Arcaro KF, J Toxicol Environ Health, Part A 2004 67 1981 1094
88. Human colon microbiota trasnform polycyclic aromatic hydrocarbons to estrogenic metablites. Van de Wiele T, Vanhaecke L, Boeckaert C, Peru K, Headly J, Verstraete W, Siciliano S, EHP 2005 113 6 10
89. Gas-Phase ambient air contaminants exhibit significant dioxin-like and estrogen-like activity in vitro. Klein GP, Hodge EM, Diamond ML, Yip A, Dann T, Stern G, Denison MS, Harper PA, EHP 2006 114 5 697 703
90. Outdoor air pollution and lung cancer. Cohen AJ, EHP 2000 108 743 750
91. Lung cancer mortality ina district of La Spezia (Italy) exposed to air pollution from industrial plants. Parodi S, Baldi R, Benco C, Franchini M, Garrone E, Vercelli M, Pensa F, Puntoni R, Fontana V, Tumori 2004 90 181 185 (Pubitemid 38745605)
92. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by the utero arsenic exposure. Shen J, Liu J, Xie Y, Diwan BA, Waalkes MP, Toxicol Sci 2007 95 2 313 320 (Pubitemid 46152603)
93. Estrogen receptor alpha polymorhism and renal cell carcinoma- possible risk. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R, Mol Cellular Endocrinol 2003 202 109 116 (Pubitemid 36593401)
94. Review of potential risk factors for kidney (renal cell) cancer. Moyad MA, Semin Urol Oncol 2001 19 280 293 (Pubitemid 33143817)
95. Cadmium and renal cancer. Ilyasova D, Schwartz GG, Toxicol Applied Pharmacol 2005 207 179 186 (Pubitemid 41133504)
96. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Hopenhayn-Rich C, Biggs ML, Smith AH, Int J Epidemiol 1998 27 561 569 (Pubitemid 28431495)
97. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Søreide K, Aagnes B, Møller B, Westgaard A, Bray F, Scand J Gastroenterol 2010 45 1 82 92
98. Pancreatic cancer epidemiology and survival in an Australia population. Luke C, Price T, Karapetis C, Singhai N, Roder D, Asian Pac J cancer Prev 2009 10 3 369 374
99. Analysis of mortality rates for pancreatic cancer across the world. Hariharan D, Saied A, Kocher HM, HPB (Oxford) 2008 10 1 58 62 (Pubitemid 351298114)
100. Cancers of the pancreas and hepatobilliary system. Sauerland C, Engelking C, Wickham R, Pearlstone DB, Seminars in Oncol Nursing 2009 25 1 76 92
101. Epidemiology and risk factors for pancreatic cancer. Lowenfels AB, Maisonneuve P, Best Practice & Res Clin Gastroenteol 2006 20 2 197 209
102. Estrogen receptor beta/alfa ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. Konduri S, Schwartz RE, J Surgical Res 2007 140 55 66 (Pubitemid 46680345)
103. Other risk factors for pancreatic cancer: hormonal aspects. Andren-Sandberg A, Hoem D, Backman PL, Ann Oncol 1999 10 Suppl 4 131 132
104. The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols. Trushin N, Leder G, El Bayoumy K, Hoffmann D, Beger HG, Henne-Bruns D, Ramadani M, Prokopcyk B, Langenbecks Ach Surg 2008 393 571 579
105. Effect of postnatal exposure to benz(a)pyrene on the uterus of immature rats. Kummer V, Maskova J, Zraly Z, Matiasovic J, Faldyna M, Exp Toxicol Pathol 2007 59 1 69 76 (Pubitemid 47223681)
106. Estrogen receptor expression in tumors different from breast cancer. Bogush TA, Dudko EA, Beme AA, Bogush EA, Polotskii BE, Tiuliandin SA, Davydov MI, Antibiot Khimioter 2009 54 7-8 41 49
107. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA, Nat Genet 2008 40 5 499 507 (Pubitemid 351601215)
108. Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours. Batistatou A, Kyzas PA, Goussia A, Arkoumani E, Voulgaris S, Polyzoidis K, Agnantis NJ, Stefanou D, J Neurol 2006 77 1 17 23 (Pubitemid 43870557)
109. Elevated testosterone induces apoptosis in neuronal cells. Estrada M, Varshney A, Ehrilich BE, Biol Chem 2006 281 35 25492 25501 (Pubitemid 44401938)
110. Association of brain cancer with residential exposure to petrochemical air pollution in Taiwan. Liu CC, Chen CC, Wu TN, Yang CY, J Toxicol Environ Health, Part A 2008 71 310 314
111. Testicular cancer variations in time and sapce in Europe. Huyghe E, Plante P, Thonneau PF, Eur Urol 2007 51 621 628 (Pubitemid 46097270)
112. TC incidence increasing: spread the word. Maffezzini M, European Urology 2007 51 596 597 (Pubitemid 46097269)
113. Estrogen receptors alpha and beta in human testis: both isoforms are expressed. Cavaco JE, Laurentino SS, Barros A, Sousa M, Socorro S, Syst Biol Reprod Med 2009 55 4 137 144
114. Developmental changes in testicular sensitivity to estrogens through feral and neonatal life. Delbes G, Duquenne C, Szenker J, Taccon J, Habert R, Levacher C, Toxicol Sci 2007 99 1 234 243 (Pubitemid 47250381)
115. Maternal lung cancer and testicular cancer risk in the offspring. Kaijser M, Akre O, Cnattinius S, Ekbom A, Cancer Epidemiol Biomarkers, Prevention 2003 12 643 646 (Pubitemid 36899845)
116. Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. Swerdlow AJ, Stiller CA, Wilson LM, J Epidemiol Community Health 1982 36 2 96 101 (Pubitemid 12071085)
117. Prenatal nicotine increase testosterone levels in the fetus and females offspring. Smith LM, Cloak CC, Poland RE, Torday J, Ross MG, Nicotine Tob Res 2003 5 3 369 374 (Pubitemid 36764033)
118. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Storgaard L, Bonde JP, Olsen J, Reprod Toxicol 2006 21 1 4 15 (Pubitemid 43048769)
119. Endocrine disrupters and female reproductive health. McLachlan JA, Simpson E, Martin M, Best Pract Res Clin Endocrinol Metab 2006 20 1 63 75 (Pubitemid 43323764)
120. The importance of ERbeta signalling in the ovary. Drummond E, Fuller PJ, J Endocrinol 2010 205 1 15 23
121. Ovarian cancer screening: recommendations for clinical pratice. Amram-Benamran ML, Cochet S, Petignat P, Sappino AP, Rev Med Suisse 2010 6 250 1066 1068
122. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Henson MC, Chedrese PJ, Exp Biol Med 2004 229 383 392 (Pubitemid 38542347)
123. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rate. Grant WB, Cancer 2002 94 1 272 281 (Pubitemid 34049069)
124. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. El-Zein R, Conforti-Froes N, Au WW, Environ Mol Mutagenesis 1997 30 196 204 (Pubitemid 27440596)
125. Alcohol consmtion, glutathione S-transferase M1 and T1 genetic polymorphysim and breast cancer risk. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, Choe KJ, Strickland PT, Hirvonen A, Kang D, Pharmacogenetics 2000 10 301 309 (Pubitemid 30345178)
126. Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strain. Wadia PR, Vanderberg LN, Schaeberle CM, Rubin BS, Sonnenschein C, Soto AM, EHP 2007 115 4 592 598 (Pubitemid 46585532)
127. Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epdegenetic mode of action is implicated. Prins GS, Tang WY, Belmonte J, Ho SM, Fertility and Strerility 2008 89 Suppl 1 41 42
128. Steroid and xenobiotic receptor (XR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Miki Y, Suzuki T, Tazawa C, Blumberg B, Sasano H, Mol Cellular Endocrinol 2005 231 75 85 (Pubitemid 40248818)